GoodRx Holdings Inc - Class A
Research GoodRx Holdings Inc - Class A (GDRX) on Bullrun: valuation model: 56.1% overvalued, market cap USD 1.18B, P/E 73.9. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerGDRX
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryHealth Information Services
- CurrencyUSD
- Valuation signal56.1% overvalued
- Market capUSD 1.18B
- P/E73.9
- Financial periodQ2 2026
- RevenueUSD 200.41M
- Net incomeUSD 8.54M
- Free cash flowUSD 66.42M
- Gross margin89.5%
Valuation Snapshot
Bullrun's latest valuation model marks GoodRx Holdings Inc - Class A as 56.1% overvalued; latest market cap is USD 1.18B; P/E is 73.9.
Peer valuation comparison
Latest P/E is 73.94x versus a Healthcare sector median of 24.46x (202.3% above).
Latest P/E is 73.94x versus a United States median of 24.87x (197.3% above).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 796.85M | USD 30.40M | USD 164.38M | 92.8% | 0.09 | USD 261.82M | USD 488.26M | USD 616.26M |
| FY2024 | USD 792.32M | USD 16.40M | USD 182.65M | 93.9% | 0.04 | USD 448.35M | USD 491.71M | USD 724.66M |
| FY2023 | USD 750.27M | -USD 8.90M | USD 137.25M | n/a | -0.02 | USD 672.30M | USD 656.49M | USD 761.96M |
| FY2022 | USD 766.55M | -USD 32.80M | USD 142.81M | n/a | -0.08 | USD 757.17M | USD 658.83M | USD 814.83M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-25 | USD 1.18B | 73.9 | n/a | n/a |
| 2025 | 2025-12-31 | USD 924.25M | 33.9 | n/a | n/a |
| 2024 | 2024-12-31 | USD 1.78B | 116.3 | n/a | n/a |
| 2023 | 2023-12-29 | USD 2.72B | 167.5 | n/a | n/a |
| 2022 | 2022-12-30 | USD 1.85B | n/a | n/a | n/a |
| 2021 | 2021-12-31 | USD 13.09B | n/a | n/a | n/a |
About GoodRx Holdings Inc - Class A
GoodRx Holdings, Inc., together with its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices.
Related stock research
Other Healthcare stocks
Frequently asked questions
Is GoodRx Holdings Inc - Class A overvalued or undervalued?
Bullrun's valuation model currently marks GoodRx Holdings Inc - Class A as 56.1% overvalued.
What is GoodRx Holdings Inc - Class A's market cap?
GoodRx Holdings Inc - Class A's market capitalization is USD 1.18B.
What is GoodRx Holdings Inc - Class A's P/E ratio?
GoodRx Holdings Inc - Class A's price-to-earnings (P/E) ratio is 73.9.
What does GoodRx Holdings Inc - Class A do?
GoodRx Holdings, Inc., together with its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices. It also offers other healthcare products and services, including subscription programs and pharma manufacturer solutions, as well as telehealth services through the GoodRx Care platform.